Explore the detailed record of transactions filed by 노성일, Chief Executive Officer. Director active across 2 companies, notably 메지온. In total, 18 disclosures have been published. History available since 18 March 2026. The latest transaction was filed on 18 March 2026 (Purchase). Regulator: DART (FSS). All data is free.
Noh Sung-Il is the Managing Director of 메지온, a company specializing in drug development. In this role, he oversees operations and research projects, contributing to the innovation and growth of the company. His expertise is essential for the success of strategic initiatives.